化脓性汗腺炎/反常性痤疮的分型进展

doi:10.35541/cjd.20210252

Abstract

Abstract: 【Abstract】 Hidradenitis suppurativa（HS）/acne inversa（AI） is a chronic, recurrent and inflammatory skin disease caused by follicular atresia with varying clinical manifestations, and there is no unified classification criteria for it in China and other countries. Based on its clinical characteristics, gene mutations and their correlations, researchers have enriched the subtype classification of HS/AI. This review summarizes recent advances in clinical phenotypes and genotypes of HS/AI as well as their relationships, in order to help clinicians better understand the disease, and provide a theoretical basis for correct diagnosis and individualized treatment strategies.

Key words: Hidradenitis suppurativa, Phenotype, Genotype, Genotype-phenotype correlation, Acne inversa

Wang Wenzhu, Wang Baoxi, He Yanyan, Xu Haoxiang. Clinical phenotypes and genotypes of hidradenitis suppurativa/acne inversa[J]. Chinese Journal of Dermatology, 2023, 56(9): 892-895.doi:10.35541/cjd.20210252

References ［30］

［1］	Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis［J］. J Am Acad Dermatol, 2020,82（5）:1045⁃1058. doi: 10.1016/j.jaad.2019. 08.090.
［2］	中国反常性痤疮/化脓性汗腺炎诊疗专家共识制订小组. 中国反常性痤疮/化脓性汗腺炎诊疗专家共识（2021版）［J］. 中华皮肤科杂志, 2021,54（2）:97⁃104. doi: 10.35541/cjd.20200802.
［3］	Hurly H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach［M］//In: Roenigk RK, Roenigk HHJr. Dermatologic surgery: principles and practice. New York: Marcel Dekker, 1989:729⁃739.
［4］	Canoui⁃Poitrine F, Le Thuaut A, Revuz JE, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross⁃sectional study［J］. J Invest Dermatol, 2013,133（6）:1506⁃1511. doi: 10.1038/jid.2012.472.
［5］	Jemec GB. Clinical practice. Hidradenitis suppurativa［J］. N Engl J Med, 2012,366（2）:158⁃164. doi: 10.1056/NEJMcp1014163.
［6］	Ingram JR, Piguet V. Phenotypic heterogeneity in hidradenitis suppurativa （acne inversa）: classification is an essential step toward personalized therapy［J］. J Invest Dermatol, 2013,133（6）:1453⁃1456. doi: 10.1038/jid.2012.476.
［7］	van der Zee HH, Jemec GB. New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes［J］. J Am Acad Dermatol, 2015,73（5 Suppl 1）:S23⁃S26. doi: 10. 1016/j.jaad.2015.07.047.
［8］	Wang B, Yang W, Wen W, et al. Gamma⁃secretase gene mutations in familial acne inversa［J］. Science, 2010,330（6007）:1065. doi: 10.1126/science.1196284.
［9］	Matusiak Ł, Szczęch J, Kaaz K, et al. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa［J］. Acta Derm Venereol, 2018,98（2）:191⁃194. doi: 10.2340/0001 5555⁃2815.
［10］	Parulkar I, Haleem H, Paek SY. Epidemiologic and clinical features of hidradenitis suppurativa［J］. Semin Cutan Med Surg, 2017,36（2）:42⁃46. doi: 10.12788/j.sder.2017.019.
［11］	Naasan H, Affleck A. Atypical hidradenitis suppurativa［J］. Clin Exp Dermatol, 2015,40（8）:891⁃893. doi: 10.1111/ced.12655.
［12］	Vural S, Baumgartner M, Lichtner P, et al. Investigation of gamma secretase gene complex mutations in German population with hidradenitis suppurativa designate a complex polygenic heritage［J］. J Eur Acad Dermatol Venereol, 2021,35（6）:1386⁃1392. doi: 10.1111/jdv.17163.
［13］	Martorell A, Jfri A, Koster S, et al. Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study［J］. J Eur Acad Dermatol Venereol, 2020,34（6）:1309⁃1318. doi: 10.1111/jdv.16183.
［14］	González⁃Manso A, Agut⁃Busquet E, Romaní J, et al. Hidradenitis suppurativa: proposal of classification in two endotypes with two⁃step cluster analysis［J］. Dermatology, 2021,237（3）:365⁃371. doi: 10.1159/000511045.
［15］	Thorlacius L, Riis PT, List EK, et al. Sub⁃classification of hidradenitis suppurativa: a cross⁃sectional study［J］. Arch Dermatol Res, 2020. doi: 10.1007/s00403⁃020⁃02149⁃z.
［16］	Frew JW, Vekic DA, Woods J, et al. A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa［J］. Br J Dermatol, 2017,177（4）:987⁃998. doi: 10.1111/bjd.15441.
［17］	Wang Z, Yan Y, Wang B. γ⁃Secretase genetics of hidradenitis suppurativa: a systematic literature review［J］. Dermatology, 2021,237（5）:698⁃704. doi: 10.1159/000512455.
［18］	Xu H, Xiao X, Hui Y, et al. Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa （acne inversa）［J］. Br J Dermatol, 2016,174（4）:927⁃929. doi: 10.1111/bjd.14268.
［19］	Li C, Xu H, Wang B. Is SAPHO syndrome linked to PASH syndrome and hidradenitis suppurativa by nicastrin mutation? a case report［J］. J Rheumatol, 2018,45（11）:1605⁃1607. doi: 10. 3899/jrheum.171007.
［20］	Pavlovsky M, Sarig O, Eskin⁃Schwartz M, et al. A phenotype combining hidradenitis suppurativa with Dowling⁃Degos disease caused by a founder mutation in PSENEN［J］. Br J Dermatol, 2018,178（2）:502⁃508. doi: 10.1111/bjd.16000.
［21］	Li C, Li W, Xu H, et al. PSENEN mutation carriers with co⁃manifestation of acne inversa （AI） and Dowling⁃Degos Disease （DDD）: is AI or DDD the subphenotype?［J］. J Invest Dermatol, 2017,137（10）:2234⁃2236. doi: 10.1016/j.jid.2017.05. 021.
［22］	Li W, Xu H, He Y, et al. Comorbidities or different entities? Phenotype variability associated with PSENEN mutations［J］. Br J Dermatol, 2019,180（1）:221⁃222. doi: 10.1111/bjd.17111.
［23］	Ralser DJ, Basmanav FB, Tafazzoli A, et al. Mutations in γ⁃secretase subunit⁃encoding PSENEN underlie Dowling⁃Degos disease associated with acne inversa［J］. J Clin Invest, 2017,127（4）:1485⁃1490. doi: 10.1172/JCI90667.
［24］	Li A, Peng Y, Taiclet LM, et al. Analysis of hidradenitis suppurativa⁃linked mutations in four genes and the effects of PSEN1⁃P242LfsX11 on cytokine and chemokine expression in macrophages［J］. Hum Mol Genet, 2019,28（7）:1173⁃1182. doi: 10.1093/hmg/ddy414.
［25］	Marzano AV, Damiani G, Ceccherini I, et al. Autoinflammation in pyoderma gangrenosum and its syndromic form （pyoderma gangrenosum, acne and suppurative hidradenitis）［J］. Br J Dermatol, 2017,176（6）:1588⁃1598. doi: 10.1111/bjd.15226.
［26］	Nguyen TV, Damiani G, Orenstein L, et al. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life［J］. J Eur Acad Dermatol Venereol, 2021,35（1）:50⁃61. doi: 10.1111/jdv.16677.
［27］	Jfri A, Litvinov IV, Netchiporouk E, et al. Novel variants of MEFV and NOD2 genes in familial hidradenitis suppurativa: a case report［J］. SAGE Open Med Case Rep, 2020,8:2050313X20953113. doi: 10.1177/2050313X20953113.
［28］	Abbara S, Georgin⁃Lavialle S, Stankovic Stojanovic K, et al. Association of hidradenitis suppurativa and familial Mediterranean fever: a case series of 6 patients［J］. Joint Bone Spine, 2017,84（2）:159⁃162. doi: 10.1016/j.jbspin.2016.02.021.
［29］	Ingram JR, Piguet V. Phenotypic heterogeneity in hidradenitis suppurativa （acne inversa）: classification is an essential step toward personalized therapy［J］. J Invest Dermatol, 2013,133（6）:1453⁃1456. doi: 10.1038/jid.2012.476.
［30］	Frew JW, Hawkes JE, Sullivan⁃Whalen M, et al. Inter⁃rater reliability of phenotypes and exploratory genotype⁃phenotype analysis in inherited hidradenitis suppurativa［J］. Br J Dermatol, 2019,181（3）:566⁃571. doi: 10.1111/bjd.17695.

[1]	Yuan Chen, Yan Yan, Wang Baoxi . Biotherapy for acne inversa [J]. Chinese Journal of Dermatology, 2023, 56(3): 270-273.
[2]	Li Wei, Li Zheng . Atopic dermatitis with typical and atypical manifestations [J]. Chinese Journal of Dermatology, 2023, 56(1): 1-4.
[3]	Zhu Ying, Guo Yunyi, Zhang Danlu, Guo Birong, Sun Zhonghui. Mutation analysis in 5 families with mild phenotypes of neurofibromatosis type 1 [J]. Chinese Journal of Dermatology, 2022, 55(6): 519-522.
[4]	Ma Xiao, Li Chengrang, Wang Baoxi, He Yanyan, Xu Haoxiang. Severity assessment criteria for acne inversa/hidradenitis suppurativa [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210236-e20210236.
[5]	Li Wenrui, Jia Weixue, Zhang Yunbin, Lin Lin, Li Chengrang. Construction of a nicastrin gene-silenced zebrafish model and a primary study on the mechanism of abnormal pigmentation [J]. Chinese Journal of Dermatology, 2021, 54(5): 402-407.
[6]	Li Wenrui, Zhang Yuanyuan, Jia Weixue, He Yanyan, Xu Haoxiang, Lin Lin, Li Chengrang, . Effect of PSENEN gene silencing on the proliferation of and γ-secretase expression in HaCaT cells [J]. Chinese Journal of Dermatology, 2021, 54(4): 318-324.
[7]	Zhou Jie, Song Zhiqiang. Clinical phenotypes and endophenotypes of atopic dermatitis [J]. Chinese Journal of Dermatology, 2021, 54(3): 259-263.
[8]	Consensus Writing Group on the Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in China. Diagnosis and treatment of acne inversa/hidradenitis suppurativa in China: an expert consensus statement （2021 version） [J]. Chinese Journal of Dermatology, 2021, 54(2): 97-104.
[9]	Shi Bei, Zhu Guannan, Fu Meng. Tumor necrosis factor-α inhibitors for the treatment of four cases of hidradenitis suppurativa [J]. Chinese Journal of Dermatology, 2021, 54(10): 901-903.
[10]	Zhang Wanlu, Zhang Yuanyuan, Wu Yingda, Cheng Ping, Li Wenrui, Xu Haoxiang, Wang Baoxi, He Yanyan, Li Chengrang. Effect of NCSTN gene silencing on the proliferation and differentiation of HaCaT cells [J]. Chinese Journal of Dermatology, 2020, 53(9): 704-709.
[11]	Li Xin, Han Jianwen. Analysis of culprit drugs and screening for human leukocyte antigen genes in patients of Han nationality with Stevens-Johnson syndrome/toxic epidermal necrolysis in Inner Mongolia [J]. Chinese Journal of Dermatology, 2020, 53(9): 680-684.
[12]	Xiao Xuemin, He Yanyan, Xu Haoxiang, Wang Baoxi, Lin Lihang. Genome-wide expression profile analysis of Nicastrin gene-silenced HaCaT cells [J]. Chinese Journal of Dermatology, 2020, 53(6): 445-451.
[13]	Wu Wei, Zheng Luyao, Pan Chaolan, Yang Ting, Li Ming. Novel desmoplakin mutations in a child with Carvajal syndrome [J]. Chinese Journal of Dermatology, 2020, 53(4): 271-274.
[14]	Zhou Pengjun, Wang Baoxi, Lin Lihang, Xiao Xuemin. γ-Secretase mutations in acne inversa [J]. Chinese Journal of Dermatology, 2019, 52(9): 656-659.
[15]	Li Suo, Li Zhiliang, Jin Ke, Xiang Ruiyu, Zhang Hanmei, Feng Suying, Lin Lin. Associations of anti-desmoglein antibodies with clinical phenotypes and disease activity in pemphigus patients and their change patterns [J]. Chinese Journal of Dermatology, 2019, 52(5): 297-301.

Clinical phenotypes and genotypes of hidradenitis suppurativa/acne inversa

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［30］

Related Articles 15

Metrics

Comments

Recommended 10